Report 3: How Might SGLT-2s Be Used in Management of T2DM?

Program: CMES Ancillary Events
Session: CMES206-An Investigative Symposium on Key Lipid and Glucose Challenges of Practice in T2DM
Clinical
This activity is supported by an independent educational grant from Amarin Pharma Inc. and Boehringer-Ingelheim Pharmaceuticals, Inc, which is made possible in part through collaboration with Eli Lilly and Company
Monday, June 17, 2013: 6:30 PM-9:30 PM
Presentation Start Time: 8:15 PM
Yerba Buena Salon 7 (San Francisco Marriott Marquis)
Lawrence Blonde*
Ochsner Medical Center, New Orleans, LA